Medical Device News Magazine

Laird Thermal Systems Unveils Micro Multistage Thermoelectric Cooler & Optical TEAs Integration Capability

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Laird Thermal Systems has developed the new OptoTEC™ MSX Series of micro multistage thermoelectric coolers and the capability to integrate them into various optical packages, including widely used TO-39, TO-46, or TO-8, creating advanced Optical Thermoelectric Assemblies (TEAs). The MSX Series utilizes advanced ceramic materials, proprietary solder bonding techniques and next-generation thermoelectric materials to boost cooling capacity by as much as 10% – all in a micro footprint. The Optical TEAs are designed for high-performance image sensing applications commonly used in analytical, industrial, and aerospace applications.

Thermal noise reduces image resolution as temperature increases. For high-end image sensing devices like IR detectors, X-ray detectors, CCD and CMOS sensors, deep cooling below ambient is required for the imaging sensor to capture maximum light spectrum.

The multistage MSX Series TECs offer micro footprints on the cold side down to 2.0 x 4.0 mm with thicknesses down to 3.3 mm for 2-stage, 3.8 mm for 3-stage and 4.9 mm for 4-stage coolers.

The packing fraction for thermoelectric elements enables a high heat pumping capacity up to 5 Watts, with lower operating currents than traditional multistage coolers. Featuring solid-state construction for long life reliability and no maintenance, the micro multistage thermoelectric coolers deliver reliable temperature stabilization from room temperature down to 180 Kelvin with no outgassing.

Manufactured in the USA, Laird Thermal Systems has invested in advanced automation equipment to integrate the multistage coolers into miniature optical packages in-house. This saves customers the burdensome task of integrating TECs into their packages, reducing assembly time and costs and improving repeatability.

“Advanced process automation has enabled a new level of miniaturization for our MSX multistage series to support next-generation imaging solutions that require smaller optical packages,” said Andrew Dereka, Thermoelectrics Product Director at Laird Thermal Systems. “Developing proprietary Optical TEA capabilities with minimal solder voiding ensures that our customers receive Optical TEAs with the highest quality, without the hassle of building assemblies themselves.”

The MSX Series is undergoing Telcordia GR-468 CORE qualification to ensure high repeatability and long-life operation in optical environments. More here.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”